BCAB- Bioatla, Inc.

Name: Bioatla, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Bioatla, Inc. (BCAB) has 4 insiders with recent SEC Form 4 filings, including 0 buys and 35 sells. BCAB is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Short Jay M Phd	2.66M	$9.72M	-
Other	Sievers Eric	598.7K	$2.19M	-
CFO	Vasquez Christian	530.2K	$1.94M	-
CFO	Waldron Richard A	343.4K	$1.26M	-

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 29, 2021	Vasquez Christian85	See Remarks	Sell	642	$23.89	$15,337.38	-2.3%	-72.8%	-56.3%
Nov 29, 2021	Smith Scott Andrew94	President	Sell	399	$23.89	$9,532.11	-0.1%	-72.8%	-56.3%
Nov 29, 2021	Sievers Eric91	Chief Medical Officer	Sell	110	$23.89	$2,627.90	-0.1%	-72.8%	-56.3%
Nov 29, 2021	Short Jay M Phd87	Chief Executive Officer	Sell	15,435	$23.89	$368,742.15	-1.1%	-72.8%	-56.3%
Nov 24, 2021	Smith Scott Andrew94	President	Sell	1,580	$25.26	$39,916.29	-	-74.1%	-61.4%
Nov 24, 2021	Vasquez Christian85	See Remarks	Sell	2,541	$25.26	$64,195.10	-1.5%	-74.1%	-61.4%
Nov 24, 2021	Short Jay M Phd87	Chief Executive Officer	Sell	57,640	$25.26	$1,456,181.80	-0.7%	-74.1%	-61.4%
Nov 24, 2021	Waldron Richard A85	Chief Financial Officer	Sell	13,333	$25.26	$336,837.89	-1.4%	-74.1%	-61.4%
Nov 24, 2021	Sievers Eric91	Chief Medical Officer	Sell	434	$25.26	$10,964.05	-	-74.1%	-61.4%
Nov 2, 2021	Steinman Lawrence64	Director	Sell	450	$30.00	$13,500.00	-2.4%	-68.1%	-78.5%

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC